HYDRALAZINE HYDROCHLORIDE
NDC 43066-041, HYDRALAZINE HYDROCHLORIDE, injection, from Baxter Healthcare Corporation.
- Product NDC
- 43066-041
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219797
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43066-041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE20 mg/mL
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43066-041-25 | 43066004125 | 25 VIAL, SINGLE-DOSE in 1 CARTON (43066-041-25) / 1 mL in 1 VIAL, SINGLE-DOSE (43066-041-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f1a10203-f027-4f9c-8dd6-907c6db24d47Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=43066-041
Use it
Look up 43066-041 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43066-041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43066-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.